Exposing Peptide Study Bias
16:00–16:43 · 43s
Greg explains how BPC-157 hasn’t advanced to human trials and alleges much of the positive research is cherry-picked or tied to patent holders with financial incentives.
16:00–16:43 · 43s
Greg explains how BPC-157 hasn’t advanced to human trials and alleges much of the positive research is cherry-picked or tied to patent holders with financial incentives.
We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.